Araris Biotech AG

📍 Au, Switzerland🗓 Founded 2019👥 23 employees💰 Last funded Oct 2024
Araris Biotech AG is pioneering a novel linker technology for antibody-drug conjugates (ADCs.) Our linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering.
9
Total investors
5
Early stage
4
Mid stage
0
Late stage
2019
Founded
Investor geography4 countries
Switzerland
5
Germany
2
Hong Kong SAR
1
United Kingdom
1
Investor activity2020–2024 · investors recorded per year
20205202212023220241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Araris Biotech AG?
Araris Biotech AG has 9 investors on record on gritt.io, including 5 early-stage backers, 4 mid-stage.
When did Araris Biotech AG last raise funding?
The most recent investment in Araris Biotech AG recorded on gritt.io was in October 2024.
When was Araris Biotech AG founded?
Araris Biotech AG was founded in 2019.
What industry is Araris Biotech AG in?
Araris Biotech AG operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Araris Biotech AG based?
Araris Biotech AG is headquartered in Au, Switzerland.